ANEUROTECH IP
Last board
2 directors, no change since 2022Director, permanent representative BUNTINX Erik Florent René Ghislain
appointed by deed of 02-05-2022
term without a fixed end
also on the board of 2 other companies
Permanent representatives 1
BUNTINX Erik Florent René Ghislain
Permanent representative, for EB Pharma Developments
appointed by deed of 02-05-2022
Mandates through the years
2 names, the dashed line is todayEB Pharma Development
Director
Director
EB Pharma Developments
Director
Director
Board
Mandates as a list
- EB Pharma Development
- Director, appointed by deed of 02-05-2022, still in office
- EB Pharma Developments
- Director, appointed by deed of 02-05-2022, still in office
Control
Founder
ANIMA
This company
ANEUROTECH IP
Capital
- Capital
- €583,341.49
- Shares
- 750
- Contribution per share
- €778
- Source
- deed of 02-05-2022
Articles of association
deed of 02-05-2022 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Algemene vergadering te allen tijde, bestuursorgaan bij meerderheid uitgebrachte stemmen”“Vergoeding bestuurder, behoudens andersluidend besluit algemene vergadering”
- Financial yearThe company draws up its annual accounts over this twelve-month period.
- From 1 January to 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Monday of June at 11:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor
Shareholders
At incorporation
deed of 02-05-2022 ↗
- ANIMA (BE 0452.135.608) 750 shares (100%)